SEC Form 4 · accession 0001144204-15-028801
MusclePharm Corp · MSLP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brad J Pyatt
Officer — Chief Executive Officer · Director
Period of report
May 6, 2015
Accepted (ET)
May 8, 2015 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001415684
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 6, 2015 | J | 100,000 | — | D | 975,443 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On May 6, 2015 the Reporting Person was informed of the involuntary sale, by a third party, of the shares pursuant to a pledge agreement dated October 15, 2014 (the "Pledge Agreement"), in accordance with the terms and conditions of such Pledge Agreement.